Blood Transfusion After Myocardial Infarction. Friend, Foe, or Double-Edged Sword?

JACC: Cardiovascular Interventions

Volumn 2, Issue 7, 2009, Pages 633-635

  Alfonso, Fernando ^a  

^a Cardiovascular Institute   (Spain)

Author keywords

acute myocardial infarction; anemia; bleeding; coronary interventions; transfusion

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADJUVANT THERAPY; ANEMIA; BLEEDING; CLINICAL TRIAL; COMORBIDITY; CONSERVATIVE TREATMENT; CORONARY STENT; EDITORIAL; ERYTHROCYTE TRANSFUSION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGE FACTORS; ANEMIA; ANGIOPLASTY, BALLOON, CORONARY; ERYTHROCYTE TRANSFUSION; HEART DISEASES; HUMANS; MYOCARDIAL INFARCTION; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 67650621366     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.05.003     Document Type: Editorial

References (12)

1. Nikolsky E., Aymong E.D., Halkin A., et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol 44 (2004) 547-553
2. Halkin A., Singh M., Nikolsky E., et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction. The CADILLAC Risk Score. J Am Coll Cardiol 45 (2005) 1397-1405
3. Gerber D.R. Transfusions of packed red blood cells in patients with ischemic heart disease. Crit Care Med 36 (2008) 1068-1074
4. Marik P.E., and Corwin H.L. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 36 (2008) 2667-2674
5. Nikolsky E., Mehran R., Sadeghi H.M., et al. Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial. J Am Coll Cardiol Intv 2 (2009) 624-632
6. Hebert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirement in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340 (1999) 409-417
7. Wu W.C., Rathore S.S., Wang Y., Radford M.J., and Krumholz H.M. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 (2001) 1230-1236
8. Jani S.M., Smith D.E., Share D., et al. Blood transfusion and in-hospital outcomes in anemic patients with myocardial infarction undergoing percutaneous coronary intervention. Clin Cardiol 30 Suppl 2 (2007) II49-II56
9. Aronson D., Dann E.J., Bonstein L., et al. Impact of red blood cell transfusion on clinical outcomes in patients with acute myocardial infarction. Am J Cardiol 102 (2008) 115-119
10. Shishehbor M.H., Madhwal S., Rajagopal V., et al. Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv 2 (2009) 46-53
11. Jolly S.S., Amlani S., Hamon M., Yusuf S., and Mehta S.R. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J 157 (2009) 132-140
12. Brasselet C., Tassan S., Nazeyrollas P., Hamon M., and Metz D. Randomised comparison of femoral versus radial approach for percutaneous coronary intervention using abciximab in acute myocardial infarction: results of the FARMI trial. Heart 93 (2007) 1556-1561